AQR Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.3M | Buy |
127,817
+69,454
| +119% | +$7.25M | 0.01% | 887 |
|
|
2025
Q1 | $6.81M | Buy |
58,363
+20,152
| +53% | +$2.35M | 0.01% | 1006 |
|
|
2024
Q4 | $3.23M | Buy |
38,211
+11,049
| +41% | +$935K | ﹤0.01% | 1282 |
|
|
2024
Q3 | $2.44M | Buy |
27,162
+14,326
| +112% | +$1.29M | ﹤0.01% | 1402 |
|
|
2024
Q2 | $1.03M | Sell |
12,836
-15,440
| -55% | -$1.24M | ﹤0.01% | 1736 |
|
|
2024
Q1 | $2.26M | Buy |
28,276
+19,946
| +239% | +$1.59M | ﹤0.01% | 1361 |
|
|
2023
Q4 | $663K | Sell |
8,330
-1,431
| -15% | -$114K | ﹤0.01% | 1758 |
|
|
2023
Q3 | $682K | Sell |
9,761
-1,946
| -17% | -$136K | ﹤0.01% | 1743 |
|
|
2023
Q2 | $841K | Buy |
11,707
+2,882
| +33% | +$207K | ﹤0.01% | 1626 |
|
|
2023
Q1 | $544K | Buy |
8,825
+148
| +2% | +$9.13K | ﹤0.01% | 1750 |
|
|
2022
Q4 | $669K | Sell |
8,677
-3,108
| -26% | -$240K | ﹤0.01% | 1712 |
|
|
2022
Q3 | $526K | Buy |
11,785
+6,089
| +107% | +$272K | ﹤0.01% | 1761 |
|
|
2022
Q2 | $218K | Buy |
+5,696
| New | +$218K | ﹤0.01% | 1972 |
|
|
2021
Q1 | – | Sell |
-6,774
| Closed | -$552K | – | 2193 |
|
|
2020
Q4 | $552K | Sell |
6,774
-7,231
| -52% | -$589K | ﹤0.01% | 1742 |
|
|
2020
Q3 | $998K | Sell |
14,005
-3,750
| -21% | -$267K | ﹤0.01% | 1405 |
|
|
2020
Q2 | $1.46M | Sell |
17,755
-3,630
| -17% | -$299K | ﹤0.01% | 1300 |
|
|
2020
Q1 | $1.26M | Sell |
21,385
-6,480
| -23% | -$381K | ﹤0.01% | 1241 |
|
|
2019
Q4 | $2.88M | Buy |
27,865
+8,277
| +42% | +$855K | ﹤0.01% | 1129 |
|
|
2019
Q3 | $396K | Buy |
+19,588
| New | +$396K | ﹤0.01% | 1828 |
|